Startups
Fresh off its $7B acquisition, Celgene is planning to open a biopharma incubator on its corporate campus in New Jersey.
Adaptimmune is making strides on becoming a fully integrated cell therapy company behind its T Cell Receptor technology
A look at the latest startups that have emerged in 2018 so far.
It appears that what Array is trying to do is focus on oncology while the new subsidiary focuses on rare diseases.
Asklepios BioPharma is forming a new biotech portfolio company, Actus Therapeutics.
Tango officially launched in 2017 and hit the ground running as a cancer drug target discovery and drug development company based on CRISPR technology.
Immune-Onc Therapeutics launched in September 2016 and is headquartered in Palo Alto, California.
Prelude Fertility was founded in late 2016 by successful startup entrepreneur Martin Varsavsky with a $200M investment.
A look at what three ex-Genentech employees have accomplished at Denali so far.
Hyalex Orthopaedics launched in May 2017 as a medical device company that intends to advance new products featuring HYALEX technology, a synthetic polymer that mimics cartilage.
PRESS RELEASES